Assessment of Cognitive Function via Biomarkers in Japanese Patients With Chronic Heart Failure Treated With Angiotensin-Receptor-Neprilysin Inhibitor
In this pilot-scale study, ARNI use was not associated with cognitive impairment or elevated blood biomarkers related to cognitive dysfunction in Japanese patients with CHF. Due to the limited sample size and follow-up, further validation in larger, long-term trials is warranted.
Authors
- Masaya Kogure
- Tomoya Kitani (ORCID: https://orcid.org/0000-0002-2696-046X)
- Fukiko Kitani‐Morii (ORCID: https://orcid.org/0000-0002-7959-4758)
- Masataka Oishi (ORCID: https://orcid.org/0000-0002-5100-4066)
- Harutsugu Tatebe
- Hirokazu Shiraishi (ORCID: https://orcid.org/0000-0002-2421-3647)
- Takahiko Tokuda (ORCID: https://orcid.org/0000-0002-7411-4911)
- Takashi Kasai
- Satoaki Matoba
Institutions
- Kyoto Prefectural University of Medicine (JP)
- National Institutes for Quantum Science and Technology (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1253/circrep.cr-24-0175
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Heart Foundation